» Articles » PMID: 22797068

MicroRNA MiR-125b Controls Melanoma Progression by Direct Regulation of C-Jun Protein Expression

Overview
Journal Oncogene
Date 2012 Jul 17
PMID 22797068
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

A fundamental event in the development and progression of malignant melanoma is the deregulation of cancer-relevant transcription factors. We recently showed that c-Jun is a main regulator of tumor progression in melanoma and thus the most important member of the AP-1 transcription factor family for this disease. Interestingly, we revealed that c-Jun expression was regulated on the post-transcriptional level and therefore speculated that miRNAs could be involved in c-Jun regulation. We determined seed sequences for miR-125b and miR-527 in the coding region of c-Jun mRNA that hints at the direct involvement of miRNA-dependent regulation on the protein level. We found that the expression of miR-125b was significantly reduced in malignant melanoma cell lines and tissue samples compared with melanocytes, whereas miR-527 remained unchanged. In further functional experiments, treatment of melanoma cells with pre-miR-125b resulted in strong suppression of cellular proliferation and migration, supporting the role of miR-125b in melanoma. In addition, transfection of pre-miR-125b led to strong downregulation of c-Jun protein but not mRNA expression in melanoma cells. Luciferase assays using reporter plasmids containing the miR-125b seed sequence in the luciferase coding region confirmed the direct interaction with miR-125b. Furthermore, immunoprecipitation of Ago-2 revealed that c-Jun mRNA accumulated in the RNA-induced silencing complex after pre-miR-125b transfection in melanoma cells. In summary, we identified an important role for miR-125b in malignant melanoma. Moreover, we demonstrated post-transcriptional regulation of c-Jun by this miRNA and showed that c-Jun is a main mediator of the effects of miR-125b on melanoma cells.

Citing Articles

Diagnostic Power of MicroRNAs in Melanoma: Integrating Machine Learning for Enhanced Accuracy and Pathway Analysis.

Rafiepoor H, Ghorbankhanloo A, Soleimani Dorcheh S, Angouraj Taghavi E, Ghanadan A, Shirkoohi R J Cell Mol Med. 2025; 29(2):e70367.

PMID: 39823244 PMC: 11740884. DOI: 10.1111/jcmm.70367.


Inhibition of circular JUN prevents the proliferation and invasion of glioblastoma via miR-3064-IGFBP5 axis.

Zhang Y, Liu S, Wu C, Gao X, Zhao H, Li O J Cell Mol Med. 2024; 28(18):e70098.

PMID: 39307884 PMC: 11416905. DOI: 10.1111/jcmm.70098.


Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma.

Staebler S, Rottensteiner-Brandl U, El Ahmad Z, Kappelmann-Fenzl M, Arkudas A, Kengelbach-Weigand A Cell Death Dis. 2024; 15(5):351.

PMID: 38773108 PMC: 11109141. DOI: 10.1038/s41419-024-06733-3.


miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine.

Piergentili R, Marinelli E, Cucinella G, Lopez A, Napoletano G, Gullo G Noncoding RNA. 2024; 10(2).

PMID: 38525735 PMC: 10961778. DOI: 10.3390/ncrna10020016.


Loss of miR-101-3p in melanoma stabilizes genomic integrity, leading to cell death prevention.

Lammerhirt L, Kappelmann-Fenzl M, Fischer S, Meier P, Staebler S, Kuphal S Cell Mol Biol Lett. 2024; 29(1):29.

PMID: 38431560 PMC: 10909299. DOI: 10.1186/s11658-024-00552-2.